Dream big with Zelira, page-709

big phama will soon realise that this is completely novel and new in drug development to be able to launch your product on day 1 with cannabis drug development and to gain a return on your investment. no waiting 10 years trial and error, billion $ and not so sure what will work. but live feedback. we have seen with the covid19 drugs their are ways to get that ROI early via the traditional method in this case - via emergency use.

Australian legal medical framework leads the way. R&D return is favourite globally. research in USA still very restrictive and when you do it's from like the 1970 degraded stockpile.

I think zelira has a fantastic continuations improvement model and get out of the way GW. this will x10 you.